Analyst Expectations For Tenet Healthcare's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided a range of evaluations for Tenet Healthcare (NYSE:THC) over the past three months, with a notable increase in price targets. The average 12-month price target is now $125.86, up 13.61% from the previous $110.78. Recent ratings have been predominantly positive, with several analysts raising their price targets and ratings.
May 30, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown increased optimism for Tenet Healthcare, raising the average 12-month price target to $125.86, a 13.61% increase from the previous target. Recent ratings have been predominantly positive, with several analysts raising their price targets and ratings.
The increase in the average 12-month price target and the predominantly positive recent ratings suggest a bullish outlook for Tenet Healthcare. This is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100